The Food and Drug Administration has cleared Boehringer Ingelhein and Lilly’s Jardiance (empagliflozin) 10 mg and 25 mg tablets to lower blood sugar in children 10 years and older with Type 2 diabetes ...
Boehringer Ingelheim and Eli Lilly have received the Food and Drug Administration's green light for Jardiance (empagliflozin) 10 mg tablets to reduce the risk of sustained decline in estimated ...
Yesterday’s FDA approvals of a new indication for empagliflozin and combination empagliflozin with metformin hydrochloride for pediatric type 2 diabetes (T2D) provide a new class of oral drugs to ...
June 20 (Reuters) - The U.S. Food and Drug Administration (FDA) on Tuesday approved Eli Lilly (LLY.N), opens new tab and partner Boehringer Ingelheim's drugs Jardiance and Synjardy to treat type 2 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback